Malignant epithelial tumor of salivary glands
ORPHA:276145DiseaseNot applicableAdult
Ассоциированные гены1
Эпидемиология24
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Annual incidence | 1-9 / 1 000 000 | 0.73 | Europe | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.85 | Austria | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.986 | Germany | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.809 | Iceland | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.737 | Ireland | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.98 | Latvia | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.817 | Malta | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.864 | Norway | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.937 | Poland | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.899 | Portugal | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.99 | Slovakia | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.657 | Slovenia | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.919 | Spain | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.906 | Switzerland | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.786 | Netherlands | Value and class |
| Annual incidence | 1-9 / 1 000 000 | 0.906 | United Kingdom | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.121 | Belgium | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.026 | Bulgaria | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.261 | Croatia | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.113 | Czech Republic | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.127 | Estonia | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.093 | Finland | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.227 | Italy | Value and class |
| Annual incidence | 1-9 / 100 000 | 1.213 | Lithuania | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)